中国抗癌协会乳腺癌诊治指南与规范（2019年版）

[1] 乳腺癌新辅助化疗后的病理诊断专家共识[J]. 杨文涛,步宏.中华病理学杂志. 2015 (04)

[2] 乳腺癌雌、孕激素受体免疫组织化学检测指南[J]. 杨文涛,步宏.中华病理学杂志. 2015 (04)

[3] Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial[J] . Eleftherios P Mamounas,Hanna Bandos,Barry C Lembersky,Jong-Hyeon Jeong,Charles E Geyer,Priya Rastogi,Louis Fehrenbacher,Mark L Graham,Stephen K Chia,Adam M Brufsky,Janice M Walshe,Gamini S Soori,Shaker R Dakhil,Thomas E Seay,James L Wade,Edward C McCarron,Soonmyung Paik,Sandra M Swain,D Lawrence Wickerham,Norman Wol

[4] Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial[J] . Debu Tripathy,Seock-Ah Im,Marco Colleoni,Fabio Franke,Aditya Bardia,Nadia Harbeck,Sara A Hurvitz,Louis Chow,Joohyuk Sohn,Keun Seok Lee,Saul Campos-Gomez,Rafael Villanueva Vazquez,Kyung Hae Jung,K Govind Babu,Paul Wheatley-Price,Michelino De Laurentiis,Young-Hyuck Im,Sherko Kuemmel,Nagi El-Saghir,Mei-Ching Liu,Gary Carlson,Gareth Hughes,Iv

[5] Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials[J] . Bernard Asselain,William Barlow,John Bartlett,Jonas Bergh,Elizabeth Bergsten-Nordstr?m,Judith Bliss,Francesco Boccardo,Clare Boddington,Jan Bogaerts,Gianni Bonadonna,Rosie Bradley,Etienne Brain,Jeremy Braybrooke,Philippe Broet,John Bryant,Julie Burrett,David Cameron,Mike Clarke,Alan Coates,Robert Coleman,Raoul Charles Coombes,Candace Cor

[6] Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial[J] . Miguel Martin,Frankie A Holmes,Bent Ejlertsen,Suzette Delaloge,Beverly Moy,Hiroji Iwata,Gunter von Minckwitz,Stephen K L Chia,Janine Mansi,Carlos H Barrios,Michael Gnant,Zorica Toma?evi?,Neelima Denduluri,Robert ?eparovi?,Erhan Gokmen,Anna Bashford,Manuel Ruiz Borrego,Sung-Bae Kim,Erik Hugger Jakobsen,Audrone Ciceniene,

[7] The spectrum of BRCA mutations and characteristics of BRCA‐associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next‐generation sequencing[J] . Guan‐Tian Lang,Jin‐Xiu Shi,Xin Hu,Chen‐Hui Zhang,Ling Shan,Chuan‐Gui Song,Zhi‐Gang Zhuang,A‐Yong Cao,Hong Ling,Ke‐Da Yu,Shan Li,Meng‐Hong Sun,Xiao‐Yan Zhou,Wei Huang,Zhi‐Ming Shao.International Journal of Cancer . 2017 (1)

[8] Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer [J]. CLINICAL CANCER RESEARCH, 2016, 22 (19) : 4859 - 4869

[9] Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial[J] . Armando E. Giuliano,Karla Ballman,Linda McCall,Peter Beitsch,Pat W. Whitworth,Peter Blumencranz,A. Marilyn Leitch,Sukamal Saha,Monica Morrow,Kelly K. Hunt.Annals of Surgery . 2016

[10] Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials[J] . The Lancet . 2015 (1000)

[1] 乳腺癌新辅助化疗后的病理诊断专家共识[J]. 杨文涛,步宏.中华病理学杂志. 2015 (04)

[2] 乳腺癌雌、孕激素受体免疫组织化学检测指南[J]. 杨文涛,步宏.中华病理学杂志. 2015 (04)

[3] Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial[J] . Eleftherios P Mamounas,Hanna Bandos,Barry C Lembersky,Jong-Hyeon Jeong,Charles E Geyer,Priya Rastogi,Louis Fehrenbacher,Mark L Graham,Stephen K Chia,Adam M Brufsky,Janice M Walshe,Gamini S Soori,Shaker R Dakhil,Thomas E Seay,James L Wade,Edward C McCarron,Soonmyung Paik,Sandra M Swain,D Lawrence Wickerham,Norman Wol

[4] Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial[J] . Debu Tripathy,Seock-Ah Im,Marco Colleoni,Fabio Franke,Aditya Bardia,Nadia Harbeck,Sara A Hurvitz,Louis Chow,Joohyuk Sohn,Keun Seok Lee,Saul Campos-Gomez,Rafael Villanueva Vazquez,Kyung Hae Jung,K Govind Babu,Paul Wheatley-Price,Michelino De Laurentiis,Young-Hyuck Im,Sherko Kuemmel,Nagi El-Saghir,Mei-Ching Liu,Gary Carlson,Gareth Hughes,Iv

[5] Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials[J] . Bernard Asselain,William Barlow,John Bartlett,Jonas Bergh,Elizabeth Bergsten-Nordstr?m,Judith Bliss,Francesco Boccardo,Clare Boddington,Jan Bogaerts,Gianni Bonadonna,Rosie Bradley,Etienne Brain,Jeremy Braybrooke,Philippe Broet,John Bryant,Julie Burrett,David Cameron,Mike Clarke,Alan Coates,Robert Coleman,Raoul Charles Coombes,Candace Cor

[6] Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial[J] . Miguel Martin,Frankie A Holmes,Bent Ejlertsen,Suzette Delaloge,Beverly Moy,Hiroji Iwata,Gunter von Minckwitz,Stephen K L Chia,Janine Mansi,Carlos H Barrios,Michael Gnant,Zorica Toma?evi?,Neelima Denduluri,Robert ?eparovi?,Erhan Gokmen,Anna Bashford,Manuel Ruiz Borrego,Sung-Bae Kim,Erik Hugger Jakobsen,Audrone Ciceniene,

[7] The spectrum of BRCA mutations and characteristics of BRCA‐associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next‐generation sequencing[J] . Guan‐Tian Lang,Jin‐Xiu Shi,Xin Hu,Chen‐Hui Zhang,Ling Shan,Chuan‐Gui Song,Zhi‐Gang Zhuang,A‐Yong Cao,Hong Ling,Ke‐Da Yu,Shan Li,Meng‐Hong Sun,Xiao‐Yan Zhou,Wei Huang,Zhi‐Ming Shao.International Journal of Cancer . 2017 (1)

[8] Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer [J]. CLINICAL CANCER RESEARCH, 2016, 22 (19) : 4859 - 4869

[9] Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial[J] . Armando E. Giuliano,Karla Ballman,Linda McCall,Peter Beitsch,Pat W. Whitworth,Peter Blumencranz,A. Marilyn Leitch,Sukamal Saha,Monica Morrow,Kelly K. Hunt.Annals of Surgery . 2016

[10] Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials[J] . The Lancet . 2015 (1000)